Adipocyte lipases and lipid droplet-associated proteins: Insight from transgenic mouse models

International Journal of Obesity

Volumn 36, Issue 4, 2012, Pages 581-594

  Girousse, A ^a,b   Langin, D ^a,b,c  

^a University Hospital of Toulouse   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

adipocyte; lipase; lipid droplet; lipolysis; PAT protein; transgenic mice

Indexed keywords

ACYLGLYCEROL LIPASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BINDING PROTEIN; DIACYLGLYCEROL; FAT DROPLET; FATTY ACID BINDING PROTEIN 4; HORMONE SENSITIVE LIPASE; MONOACYLGLYCEROL; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ADIPOSE TISSUE; DNA MICROARRAY; ENERGY EXPENDITURE; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC MANIPULATION; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOLYSIS; METABOLIC DISORDER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; TRANSGENIC ANIMAL; WEIGHT GAIN;

ADIPOCYTES; ANIMALS; CARRIER PROTEINS; CONTACTIN 2; FATTY ACID-BINDING PROTEINS; LIPOLYSIS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; STEROL ESTERASE; TRIGLYCERIDES;

MUS MUSCULUS;

EID: 84859631366     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.113     Document Type: Review

References (110)

1. Bezaire V, Langin D. Regulation of adipose tissue lipolysis revisited. Proc Nutr Soc 2009; 68: 350-360.
2. Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 2009; 48: 275-297.
3. Brasaemle DL. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res 2007; 48: 2547-2559. (Pubitemid 350272839)
4. Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011; 50: 14-27.
5. Marcinkiewicz A, Gauthier D, Garcia A, Brasaemle DL. The phosphorylation of serine 492 of perilipin a directs lipid droplet fragmentation and dispersion. J Biol Chem 2006; 281: 11901-11909. (Pubitemid 43855452)
6. Bezaire V, Mairal A, Ribet C, Lefort C, Girousse A, Jocken J et al. Contribution of adipose triglyceride lipase and hormone-sensitive lipase to lipolysis in hMADS adipocytes. J Biol Chem 2009; 284: 18282-18291.
7. Subramanian V, Rothenberg A, Gomez C, Cohen AW, Garcia A, Bhattacharyya S et al. Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J Biol Chem 2004; 279: 42062-42071. (Pubitemid 39313657)
8. Yamaguchi T, Omatsu N, Matsushita S, Osumi T. CGI-58 interacts with perilipin and is localized to lipid droplets. Possible involvement of CGI-58 mislocalization in Chanarin-Dorfman syndrome. J Biol Chem 2004; 279: 30490-30497. (Pubitemid 38937979)
9. Haemmerle G, Zimmermann R, Hayn M, Theussl C, Waeg G, Wagner E et al. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J Biol Chem 2002; 277: 4806-4815. (Pubitemid 34968514)
10. Osuga J, Ishibashi S, Oka T, Yagyu H, Tozawa R, Fujimoto A et al. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA 2000; 97: 787-792. (Pubitemid 30070388)
11. Mulder H, Sorhede-Winzell M, Contreras JA, Fex M, Strom K, Ploug T et al. Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. J Biol Chem 2003; 278: 36380-36388. (Pubitemid 37139966)
12. Wang SP, Laurin N, Himms-Hagen J, Rudnicki MA, Levy E, Robert MF et al. The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes Res 2001; 9: 119-128. (Pubitemid 33603838)
13. Fredrikson G, Tornqvist H, Belfrage P. Hormone-sensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylglycerol. Biochim Biophys Acta 1986; 876: 288-293. (Pubitemid 16014863)
14. Fortier M, Soni K, Laurin N, Wang SP, Mauriege P, Jirik FR et al. Human hormone-sensitive lipase (HSL): expression in white fat corrects the white adipose phenotype of HSL-deficient mice. J Lipid Res 2005; 46: 1860-1867. (Pubitemid 41248482)
15. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46: 2347-2355. (Pubitemid 41532523)
16. Harada K, Shen WJ, Patel S, Natu V, Wang J, Osuga J et al. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice. Am J Physiol Endocrinol Metab 2003; 285: E1182-E1195. (Pubitemid 37464368)
17. Park SY, Kim HJ, Wang S, Higashimori T, Dong J, Kim YJ et al. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart. Am J Physiol Endocrinol Metab 2005; 289: E30-E39. (Pubitemid 40874931)
18. Fortier M, Wang SP, Mauriege P, Semache M, Mfuma L, Li H et al. Hormone-sensitive lipase-independent adipocyte lipolysis during beta-adrenergic stimulation, fasting, and dietary fat loading. Am J Physiol Endocrinol Metab 2004; 287: E282-E288. (Pubitemid 38943894)
19. Sekiya M, Osuga J, Okazaki H, Yahagi N, Harada K, Shen WJ et al. Absence of hormone-sensitive lipase inhibits obesity and adipogenesis in Lep ob/ob mice. J Biol Chem 2004; 279: 15084-15090. (Pubitemid 38618902)
20. Strom K, Hansson O, Lucas S, Nevsten P, Fernandez C, Klint C et al. Attainment of brown adipocyte features in white adipocytes of hormone-sensitive lipase null mice. PLoS One 2008; 3: e1793.
21. Zimmermann R, Haemmerle G, Wagner EM, Strauss JG, Kratky D, Zechner R. Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormone-sensitive lipase-deficient white adipose tissue. J Lipid Res 2003; 44: 2089-2099. (Pubitemid 37509624)
22. Shen WJ, Yu Z, Patel S, Jue D, Liu LF, Kraemer FB. Hormone-sensitive lipase modulates adipose metabolism through PPAR-gamma. Biochim Biophys Acta 2011; 1811: 9-16.
23. Okazaki H, Osuga J, Tamura Y, Yahagi N, Tomita S, Shionoiri F et al. Lipolysis in the absence of hormone-sensitive lipase: evidence for a common mechanism regulating distinct lipases. Diabetes 2002; 51: 3368-3375. (Pubitemid 35403438)
24. Wood RJ. Vitamin D and adipogenesis: new molecular insights. Nutr Rev 2008; 66: 40-46. (Pubitemid 351666660)
25. Hansson O, Strom K, Guner N, Wierup N, Sundler F, Hoglund P et al. Inflammatory response in white adipose tissue in the non-obese hormone-sensitive lipase null mouse model. J Proteome Res 2006; 5: 1701-1710. (Pubitemid 44036144)
26. Strom K, Gundersen TE, Hansson O, Lucas S, Fernandez C, Blomhoff R et al. Hormone-sensitive lipase (HSL) is also a retinyl ester hydrolase: evidence from mice lacking HSL. FASEB J 2009; 23: 2307-2316.
27. Haemmerle G, Zimmermann R, Strauss JG, Kratky D, Riederer M, Knipping G et al. Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle. J Biol Chem 2002; 277: 12946-12952. (Pubitemid 34952662)
28. Voshol PJ, Haemmerle G, Ouwens DM, Zimmermann R, Zechner R, Teusink B et al. Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice. Endocrinology 2003; 144: 3456-3462. (Pubitemid 36904422)
29. Roduit R, Masiello P, Wang SP, Li H, Mitchell GA, Prentki M. A role for hormone-sensitive lipase in glucose-stimulated insulin secretion: a study in hormone-sensitive lipase-deficient mice. Diabetes 2001; 50: 1970-1975. (Pubitemid 33643662)
30. Peyot ML, Nolan CJ, Soni K, Joly E, Lussier R, Corkey BE et al. Hormone-sensitive lipase has a role in lipid signaling for insulin secretion but is nonessential for the incretin action of glucagon-like peptide 1. Diabetes 2004; 53: 1733-1742. (Pubitemid 38857031)
31. Fex M, Haemmerle G, Wierup N, Dekker-Nitert M, Rehn M, Ristow M et al. A beta cell-specific knockout of hormone-sensitive lipase in mice results in hyperglycaemia and disruption of exocytosis. Diabetologia 2009; 52: 271-280.
32. Lucas S, Tavernier G, Tiraby C, Mairal A, Langin D. Expression of human hormone-sensitive lipase in white adipose tissue of transgenic mice increases lipase activity but does not enhance in vitro lipolysis. J Lipid Res 2003; 44: 154-163. (Pubitemid 36114781)
33. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004; 306: 1383-1386. (Pubitemid 39532517)
34. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 2004; 279: 48968-48975. (Pubitemid 39625778)
35. Villena JA, Roy S, Sarkadi-Nagy E, Kim KH, Sul HS. Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem 2004; 279: 47066-47075. (Pubitemid 39518362)
36. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734-737.
37. Schoiswohl G, Schweiger M, Schreiber R, Gorkiewicz G, Preiss-Landl K, Taschler U et al. Adipose triglyceride lipase plays a key role in the supply of the working muscle with fatty acids. J Lipid Res 2010; 51: 490-499.
38. Hoy AJ, Bruce CR, Turpin SM, Morris AJ, Febbraio MA, Watt MJ. Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation. Endocrinology 2011; 152: 48-58.
39. Huijsman E, van de Par C, Economou C, van der Poel C, Lynch GS, Schoiswohl G et al. Adipose triacylglycerol lipase deletion alters whole body energy metabolism and impairs exercise performance in mice. Am J Physiol Endocrinol Metab 2009; 297: E505-E513.
40. Peyot ML, Guay C, Latour MG, Lamontagne J, Lussier R, Pineda M et al. Adipose triglyceride lipase is implicated in fuel- and non-fuel-stimulated insulin secretion. J Biol Chem 2009; 284: 16848-16859.
41. Kienesberger PC, Lee D, Pulinilkunnil T, Brenner DS, Cai L, Magnes C et al. Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling. J Biol Chem 2009; 284: 30218-30229.
42. Ahmadian M, Duncan RE, Varady KA, Frasson D, Hellerstein MK, Birkenfeld AL et al. Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity. Diabetes 2009; 58: 855-866.
43. Kershaw EE, Hamm JK, Verhagen LA, Peroni O, Katic M, Flier JS. Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes 2006; 55: 148-157. (Pubitemid 43343310)
44. Smirnova E, Goldberg EB, Makarova KS, Lin L, Brown WJ, Jackson CL. ATGL has a key role in lipid droplet/adiposome degradation in mammalian cells. EMBO Rep 2006; 7: 106-113.
45. Tornqvist H, Nilsson-Ehle P, Belfrage P. Enzymes catalyzing the hydrolysis of long-chain monoacyglycerols in rat adipose tissue. Biochim Biophys Acta 1978; 530: 474-486. (Pubitemid 9016123)
46. Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem 1997; 272: 27218-27223. (Pubitemid 27452682)
47. Taschler U, Radner FPW, Heier C, Schreiber R, Schweiger M, Schoiswohl G et al. Monoglyceride lipase-deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J Biol Chem 2011; 286: 17467-17477.
48. Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG et al. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 2010; 13: 1113-1119.
49. Dolinsky VW, Gilham D, Alam M, Vance DE, Lehner R. Triacylglycerol hydrolase: role in intracellular lipid metabolism. Cell Mol Life Sci 2004; 61: 1633-1651. (Pubitemid 38962045)
50. Okazaki H, Igarashi M, Nishi M, Tajima M, Sekiya M, Okazaki S et al. Identification of a novel member of the carboxylesterase family that hydrolyzes triacylglycerol: a potential role in adipocyte lipolysis. Diabetes 2006; 55: 2091-2097. (Pubitemid 44509984)
51. Gao J, Simon M. Identification of a novel keratinocyte retinyl ester hydrolase as a transacylase and lipase. J Invest Dermatol 2005; 124: 1259-1266. (Pubitemid 40847414)
52. Dolinsky VW, Sipione S, Lehner R, Vance DE. The cloning and expression of a murine triacylglycerol hydrolase cDNA and the structure of its corresponding gene. Biochim Biophys Acta 2001; 1532: 162-172. (Pubitemid 32706436)
53. Soni KG, Lehner R, Metalnikov P, O'Donnell P, Semache M, Gao W et al. Carboxylesterase 3 (EC 3.1.1.1) is a major adipocyte lipase. J Biol Chem 2004; 279: 40683-40689. (Pubitemid 39287663)
54. Wei E, Gao W, Lehner R. Attenuation of adipocyte triacylglycerol hydrolase activity decreases basal fatty acid efflux. J Biol Chem 2007; 282: 8027-8035. (Pubitemid 47093589)
55. Schweiger M, Schreiber R, Haemmerle G, Lass A, Fledelius C, Jacobsen P et al. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 2006; 281: 40236-40241. (Pubitemid 46041828)
56. Wei E, Ben Ali Y, Lyon J, Wang H, Nelson R, Dolinsky VW et al. Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. Cell Metab 2010; 11: 183-193.
57. Lefevre C, Jobard F, Caux F, Bouadjar B, Karaduman A, Heilig R et al. Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/ thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet 2001; 69: 1002-1012. (Pubitemid 33015815)
58. Lass A, Zimmermann R, Haemmerle G, Riederer M, Schoiswohl G, Schweiger M et al. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab 2006; 3: 309-319.
59. Granneman JG, Moore HP, Krishnamoorthy R, Rathod M. Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl). J Biol Chem 2009; 284: 34538-34544.
60. Granneman JG, Moore HP, Granneman RL, Greenberg AS, Obin MS, Zhu Z. Analysis of lipolytic protein trafficking and interactions in adipocytes. J Biol Chem 2007; 282: 5726-5735. (Pubitemid 47093761)
61. Yamaguchi T, Omatsu N, Morimoto E, Nakashima H, Ueno K, Tanaka T et al. CGI-58 facilitates lipolysis on lipid droplets but is not involved in the vesiculation of lipid droplets caused by hormonal stimulation. J Lipid Res 2007; 48: 1078-1089. (Pubitemid 46708675)
62. Yang X, Lu X, Lombes M, Rha GB, Chi YI, Guerin TM et al. The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab 2010; 11: 194-205.
63. Radner FP, Streith IE, Schoiswohl G, Schweiger M, Kumari M, Eichmann TO et al. Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58). J Biol Chem 2010; 285: 7300-7311.
64. Brasaemle DL. Lipolysis control: the plot thickens. Cell Metab 2010; 11: 173-174.
65. Hertzel AV, Bennaars-Eiden A, Bernlohr DA. Increased lipolysis in transgenic animals overexpressing the epithelial fatty acid binding protein in adipose cells. J Lipid Res 2002; 43: 2105-2111. (Pubitemid 35471078)
66. Maeda K, Uysal KT, Makowski L, Gorgun CZ, Atsumi G, Parker RA et al. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 2003; 52: 300-307. (Pubitemid 36173182)
67. Jenkins-Kruchten AE, Bennaars-Eiden A, Ross JR, Shen WJ, Kraemer FB, Bernlohr DA. Fatty acid-binding protein-hormone-sensitive lipase interaction. Fatty acid dependence on binding. J Biol Chem 2003; 278: 47636-47643. (Pubitemid 37523208)
68. Shen WJ, Sridhar K, Bernlohr DA, Kraemer FB. Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein. Proc Natl Acad Sci USA 1999; 96: 5528-5532. (Pubitemid 29234651)
69. Smith AJ, Sanders MA, Thompson BR, Londos C, Kraemer FB, Bernlohr DA. Physical association between the adipocyte fatty acid-binding protein and hormone-sensitive lipase: a fluorescence resonance energy transfer analysis. J Biol Chem 2004; 279: 52399-52405. (Pubitemid 39656616)
70. Smith AJ, Thompson BR, Sanders MA, Bernlohr DA. Interaction of the adipocyte fatty acid-binding protein with the hormone-sensitive lipase: regulation by fatty acids and phosphorylation. J Biol Chem 2007; 282: 32424-32432. (Pubitemid 350106440)
71. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996; 274: 1377-1379. (Pubitemid 26391462)
72. Coe NR, Simpson MA, Bernlohr DA. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res 1999; 40: 967-972. (Pubitemid 29220539)
73. Baar RA, Dingfelder CS, Smith LA, Bernlohr DA, Wu C, Lange AJ et al. Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-)mice. Am J Physiol Endocrinol Metab 2005; 288: E187-E193. (Pubitemid 40023806)
74. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 2000; 141: 3388-3396. (Pubitemid 32269028)
75. Kimmel AR, Brasaemle DL, McAndrews-Hill M, Sztalryd C, Londos C. Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins. J Lipid Res 2010; 51: 468-471.
76. Martinez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BH, Quast MJ et al. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 2000; 26: 474-479.
77. Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, Gavrilova O et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 2001; 98: 6494-6499. (Pubitemid 32488265)
78. Castro-Chavez F, Yechoor VK, Saha PK, Martinez-Botas J, Wooten EC, Sharma S et al. Coordinated upregulation of oxidative pathways and downregulation of lipid biosynthesis underlie obesity resistance in perilipin knockout mice: a microarray gene expression profile. Diabetes 2003; 52: 2666-2674. (Pubitemid 37339695)
79. Saha PK, Kojima H, Martinez-Botas J, Sunehag AL, Chan L. Metabolic adaptations in the absence of perilipin: increased beta-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipin-null mice. J Biol Chem 2004; 279: 35150-35158. (Pubitemid 39100511)
80. Miyoshi H, Souza SC, Endo M, Sawada T, Perfield II JW, Shimizu C et al. Perilipin overexpression in mice protects against diet-induced obesity. J Lipid Res 2010; 51: 975-982.
81. Sawada T, Miyoshi H, Shimada K, Suzuki A, Okamatsu-Ogura Y, Perfield II JW et al. Perilipin overexpression in white adipose tissue induces a brown fat-like phenotype. PLoS One 2011; 5: e14006.
82. Chang BH, Li L, Paul A, Taniguchi S, Nannegari V, Heird WC et al. Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol Cell Biol 2006; 26: 1063-1076. (Pubitemid 43146498)
83. Bell M, Wang H, Chen H, McLenithan JC, Gong DW, Yang RZ et al. Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance. Diabetes 2008; 57: 2037-2045.
84. Beller M, Sztalryd C, Southall N, Bell M, Jackle H, Auld DS et al. COPI complex is a regulator of lipid homeostasis. PLoS Biol 2008; 6: e292.
85. Inohara N, Koseki T, Chen S, Wu X, Nunez G. CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. EMBO J 1998; 17: 2526-2533. (Pubitemid 28221188)
86. Zhou Z, Yon Toh S, Chen Z, Guo K, Ng CP, Ponniah S et al. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet 2003; 35: 49-56. (Pubitemid 37048595)
87. Li JZ, Ye J, Xue B, Qi J, Zhang J, Zhou Z et al. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation. Diabetes 2007; 56: 2523-2532. (Pubitemid 47523259)
88. Qi J, Gong J, Zhao T, Zhao J, Lam P, Ye J et al. Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue. EMBO J 2008; 27: 1537-1548. (Pubitemid 351794037)
89. Ye J, Li JZ, Liu Y, Li X, Yang T, Ma X et al. Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. Cell Metab 2009; 9: 177-190.
90. Danesch U, Hoeck W, Ringold GM. Cloning and transcriptional regulation of a novel adipocyte-specific gene, FSP27. CAAT-enhancer-binding protein (C/EBP) and C/EBP-like proteins interact with sequences required for differentiation-dependent expression. J Biol Chem 1992; 267: 7185-7193.
91. Puri V, Konda S, Ranjit S, Aouadi M, Chawla A, Chouinard M et al. Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J Biol Chem 2007; 282: 34213-34218. (Pubitemid 350159455)
92. Toh SY, Gong J, Du G, Li JZ, Yang S, Ye J et al. Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice. PLoS One 2008; 3: e2890.
93. Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, Mizunoya W et al. FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest 2008; 118: 2808-2821.
94. Langin D. Recruitment of brown fat and conversion of white into brown adipocytes: strategies to fight the metabolic complications of obesity? Biochim Biophys Acta 2010; 1801: 372-376.
95. Farese Jr RV, Walther TC. Lipid droplets finally get a little R-E-S-P-E-C-T. Cell 2009; 139: 855-860.
96. Ross SR, Graves RA, Greenstein A, Platt KA, Shyu HL, Mellovitz B et al. A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc Natl Acad Sci USA 1990; 87: 9590-9594. (Pubitemid 120016489)
97. Martens K, Bottelbergs A, Baes M. Ectopic recombination in the central and peripheral nervous system by aP2/FABP4-Cre mice: implications for metabolism research. FEBS Lett 2010; 584: 1054-1058.
98. Urs S, Harrington A, Liaw L, Small D. Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Transgenic Res 2006; 15: 647-653. (Pubitemid 44401444)
99. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 2001; 7: 699-705. (Pubitemid 32588026)
100. Mao J, Yang T, Gu Z, Heird WC, Finegold MJ, Lee B et al. aP2-Cre-mediated inactivation of acetyl-CoA carboxylase 1 causes growth retardation and reduced lipid accumulation in adipose tissues. Proc Natl Acad Sci USA 2009; 106: 17576-17581.
101. Van Dyck F, Scroyen I, Declercq J, Sciot R, Kahn B, Lijnen R et al. aP2-Cre-mediated expression activation of an oncogenic PLAG1 transgene results in cavernous angiomatosis in mice. Int J Oncol 2008; 32: 33-40. (Pubitemid 351176059)
102. Wang ZV, Deng Y, Wang QA, Sun K, Scherer PE. Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression. Endocrinology 2010; 151: 2933-2939.
103. Langin D, Dicker A, Tavernier G, Hoffstedt J, Mairal A, Ryden M et al. Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 2005; 54: 3190-3197. (Pubitemid 43334374)
104. Jocken JW, Langin D, Smit E, Saris WH, Valle C, Hul GB et al. Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J Clin Endocrinol Metab 2007; 92: 2292-2299. (Pubitemid 46997136)
105. Ahren B. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice. Acta Physiol Scand 2001; 171: 161-167. (Pubitemid 33757150)
106. Wang M, Fotsch C. Small-molecule compounds that modulate lipolysis in adipose tissue: targeting strategies and molecular classes. Chem Biol 2006; 13: 1019-1027. (Pubitemid 44557076)
107. Ebdrup S, Refsgaard HH, Fledelius C, Jacobsen P. Synthesis and structure-activity relationship for a novel class of potent and selective carbamate-based inhibitors of hormone selective lipase with acute in vivo antilipolytic effects. J Med Chem 2007; 50: 5449-5456. (Pubitemid 350057854)
108. Long JZ, Nomura DK, Cravatt BF. Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. Chem Biol 2009; 16: 744-753.
109. Gilham D, Ho S, Rasouli M, Martres P, Vance DE, Lehner R. Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion. FASEB J 2003; 17: 1685-1687.
110. Leung D, Hardouin C, Boger DL, Cravatt BF. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat Biotechnol 2003; 21: 687-691. (Pubitemid 36638097)